Intel Executive Dr. Ann Kelleher Honored with FDI Hero Award in Ireland

Dr. Ann Kelleher receives the prestigious FDI Hero Award at the 2024 Invest In Ireland awards 

News

  • March 14, 2024

  • Contact Intel PR

  • Follow Intel Newsroom on social:

    Twitter logo
    YouTube Icon

author-image

By

Michael Lohan, CEO of the IDA presents Executive VP Dr Ann Kelleher with the FDA Hero Award 

At the Invest In Ireland awards 2024, held on March 7th, Intel’s Dr. Ann Kelleher was honoured with a very special recognition – the FDI Hero award.

Since 2018 The Invest In Ireland Awards have rewarded excellence in the inward foreign direct investment sector in the Republic of Ireland. The FDI Hero Award is a highlight of the event and is selected by a panel of judges to recognise an individual who has made an outstanding contribution to the FDI ecosystem in Ireland.

The award was introduced and presented by IDA CEO Michael Lohan. The IDA are a key supporter of the Invest In Ireland awards. Dr. Ann Kelleher was chosen as the FDI Hero award recipient based on her outstanding accomplishments in the technology industry.   

Dr. Ann Kelleher is the Executive Vice President and General Manager of Foundry Technology Development at Intel Corporation, where she is responsible for the research, development, and deployment of next-generation silicon logic, packaging, and test technologies that are the driving force behind Intel's innovation. Hailing from Macroom, Co. Cork, Dr. Kelleher is a distinguished alumna of University College Cork, where she achieved First Class honours degree and Masters in Engineering. Dr Kelleher then made history by becoming the first woman to receive a PhD from the National Microelectronics Research Centre, the precursor to the Tyndall National Institute.

Intel is currently delivering on an ambitious goal of introducing five new process nodes in four years, aiming to achieve process leadership by 2025. This complex task relies on a strong global partnership between Intel’s Technology Development organisation in Oregon, headed up by Dr. Kelleher, and Intel’s high-volume manufacturing facilities worldwide.

A key part of this partnership is the technology transfer. In the case of Intel 4, process development and early manufacturing were performed in Oregon, while Fab 34 in Leixlip focused on running diagnostics across segments of the production line. The official opening of Fab 34 in September of last year marked a critical milestone as the Intel 4 technology was officially passed from the team in Oregon to the high-volume facility in Leixlip, where production is now underway.

Dr. Kelleher is an innovator, a true pioneer in the technology and manufacturing industries, and a proud representative of Ireland on the global stage.